Praxis Precision Medicines, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Praxis Precision Medicines, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Praxis Precision Medicines, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$56.8M, a 123% decline year-over-year.
  • Praxis Precision Medicines, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$164M, a 17.1% decline year-over-year.
  • Praxis Precision Medicines, Inc. annual Operating Income (Loss) for 2023 was -$126M, a 41.2% increase from 2022.
  • Praxis Precision Medicines, Inc. annual Operating Income (Loss) for 2022 was -$215M, a 28.5% decline from 2021.
  • Praxis Precision Medicines, Inc. annual Operating Income (Loss) for 2021 was -$167M, a 170% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$126M +$88.6M +41.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$215M -$47.7M -28.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$167M -$105M -170% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-07
2020 -$62M -$26.2M -73.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 -$35.8M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.